Larvol Delta - A-Study-to-Assess-the-Effectiveness-and-Safety-of-Canakinumab-in-Clinical-Use-in-Patients-With-Schnitzler39s-Syndrome

Ilaris (canakinumab) - Novartis

http://clinicaltrials.gov/ct2/show/NCT07598422

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next